Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Pediatric Psychiatry Clinical Trials

Psychiatry Clinical Trials at Children’s National Hospital are conducted by Adelaide Robb, M.D. Dr. Robb has been participating in pediatric clinical trials since 1999 for a variety of conditions, such as depression, ADHD, schizophrenia, and bipolar disorder.

Currently Enrolling Clinical Trials

Study Coordinators can be reached by email at Elizabeth Hobbs and Rachel Reed or by phone at 202-476-6067.


A Double-blind, Placebo- and Active-controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Pediatric Patients 7-17 Years With Major Depressive Disorder

The objective of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran compared with placebo in pediatric outpatients (7-17 years) with major depressive disorder (MDD).

Full study details on


Interventional, randomized, double-blind, placebo-controlled, active reference (fluoxetine), fixed-dose study of vortioxetine in paediatric patients aged 7 to 11 years, with Major depressive disorder (MDD)

This study looks at the efficacy and safety of the investigational medicine vortioxetine compared to placebo in treating depression in children ages 7-11. Qualified children will come in for 13 appointments over the course of approximately 16 weeks.

Full study details on


Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial (TPAC)

This study will compare the effectiveness of parent stimulant medication plus behavioral parent training (BPT) versus BPT alone on child ADHD-related impairment.

Full study details on